Department of Pharmacology
-
June 29, 2023
Study identifies key regulator of melanoma development
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. -
June 5, 2023
Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD
Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79. -
May 18, 2023
A critical skin enzyme
Detailed studies of the enzymatic properties of PNPLA1 support the requirement for this protein in skin barrier formation. -
April 20, 2023
Pharmacology research symposium set for April 28
Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died last year. -
January 12, 2023
Roden honored for his leadership in precision medicine
Vanderbilt's Dan Roden, MD, will receive the PMWC 2023 Pioneer Award Jan. 27 during this year’s Precision Medicine World Conference. -
December 19, 2022
Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples
BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples. -
October 17, 2022
Three Vanderbilt faculty elected to the National Academy of Medicine
Three Vanderbilt University faculty members have been elected this year to membership in the National Academy of Medicine, a prestigious, non-governmental organization that advises the nation and the world on important aspects of medical science, health care and public health.